CLINICAL_TRIALS
trial_result
· 2022-03-31
Clinical Trial Update: A Usability Study of External Neuromodulation With iTEAR100 Generation 2 [Phase 4]
Summary
A Phase 4 usability study of the iTEAR100 Generation 2 external neuromodulation device for dry eye syndromes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Olympic Ophthalmics, Inc. | Conditions: Dry Eye Syndromes | Phase 4 | Status: UNKNOWN